Indian Council of Medical Research

IISc start-up gets regulatory approvals for COVID-19 test

IISc start-up gets regulatory approvals for COVID-19 test

New Delhi: PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a significant breakthrough in developing a first-of-its-kind, semi-quantitative electrochemical ELISA test for COVID-19 IgM and IgG antibodies. PathShodh has received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation (CDSCO), after due diligence validation at the Translational Health Science and Technology Institute (THSTI), Faridabad, as per the requirements of the Indian Council of Medical Research (ICMR). The novelty of the technology is based on the measurement of electrochemical redox activity of IgM…
Read More